We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Plasticell, Singapore Academic Institutions Collaborate

Read time: Less than a minute

Plasticell has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline.

 

“We are delighted to have put together this collaboration which has such enormous potential for the creation of next-generation stem cell products,” commented Dr Yen Choo, founder and Executive Chairman of Plasticell. 

 

Separate agreements with the two Singapore research centres encompass technology licensing, collaborative research and scientific exchange visits.

 

Plasticell will initially collaborate with the laboratories of Prof. Peter Dröge (School of Biological Sciences, NTU) and Dr. Farid Ghadessy (p53Lab, A*STAR) to apply proprietary genome editing technology to insert functional multi-transgene cassettes into specific loci of human stem cell lines. The engineered lines will be used by Plasticell in multiple projects focused on precisely directed stem cell differentiation, phenotypic screening for drug discovery and in next-generation immuno-oncology applications.